<HashMap><database>biostudies-literature</database><scores/><additional><submitter>MacDonald A</submitter><funding>NIDCR NIH HHS</funding><funding>NCI NIH HHS</funding><funding>National Institutes of Health</funding><pagination>755995</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8599986</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>12</volume><pubmed_abstract>The phospholipid phosphatidylserine (PS) is naturally maintained on the cytoplasmic side of the plasma membrane. Independent of apoptosis, PS is redistributed to the surface of CD8 T cells in response to TCR-mediated activation. Annexin V (AnnV) is a protein known to bind PS with high affinity and has been effectively utilized to anchor antigen to the surface of CD8 T cells. To expand these studies, we aimed to exploit TCR activation driven PS exposure as a target to deliver cytokine, namely interleukin-2 (IL-2), to the surface of CD8 T cells. This was accomplished using a novel chimeric fusion protein of annexin V and interleukin 2 (AnnV-IL2). &lt;i>In vitro&lt;/i> analysis revealed that AnnV-IL2 is able to specifically bind PS on the T cell surface following TCR stimulation. Consequently, AnnV</pubmed_abstract><journal>Frontiers in immunology</journal><pubmed_title>Delivery of IL-2 to the T Cell Surface Through Phosphatidylserine Permits Robust Expansion of CD8 T Cells.</pubmed_title><pmcid>PMC8599986</pmcid><funding_grant_id>R21 DE029910</funding_grant_id><funding_grant_id>NIH/NCI P50CA098252, NIH/NCI R01CA233486 , R21CA234516, R21DE029910, 5F31CA236051</funding_grant_id><funding_grant_id>R01 CA233486</funding_grant_id><funding_grant_id>P50 CA098252</funding_grant_id><funding_grant_id>F31 CA236051</funding_grant_id><funding_grant_id>R21 CA234516</funding_grant_id><pubmed_authors>MacDonald A</pubmed_authors><pubmed_authors>Lam B</pubmed_authors><pubmed_authors>Hung CF</pubmed_authors><pubmed_authors>Kung YJ</pubmed_authors><pubmed_authors>Lin J</pubmed_authors><pubmed_authors>Ferrall L</pubmed_authors><pubmed_authors>Tsai YC</pubmed_authors><pubmed_authors>Wu TC</pubmed_authors></additional><is_claimable>false</is_claimable><name>Delivery of IL-2 to the T Cell Surface Through Phosphatidylserine Permits Robust Expansion of CD8 T Cells.</name><description>The phospholipid phosphatidylserine (PS) is naturally maintained on the cytoplasmic side of the plasma membrane. Independent of apoptosis, PS is redistributed to the surface of CD8 T cells in response to TCR-mediated activation. Annexin V (AnnV) is a protein known to bind PS with high affinity and has been effectively utilized to anchor antigen to the surface of CD8 T cells. To expand these studies, we aimed to exploit TCR activation driven PS exposure as a target to deliver cytokine, namely interleukin-2 (IL-2), to the surface of CD8 T cells. This was accomplished using a novel chimeric fusion protein of annexin V and interleukin 2 (AnnV-IL2). &lt;i>In vitro&lt;/i> analysis revealed that AnnV-IL2 is able to specifically bind PS on the T cell surface following TCR stimulation. Consequently, AnnV</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021</publication><modification>2025-06-01T00:03:13.477Z</modification><creation>2025-06-01T00:03:13.477Z</creation></dates><accession>S-EPMC8599986</accession><cross_references><pubmed>34804041</pubmed><doi>10.3389/fimmu.2021.755995</doi></cross_references></HashMap>